Educational lectures from international speaker as well as in-depth discussion with our local key expert for chronic myeloid leukemia (CML) management with the addition of new class of drug, STAMP inhibitors for early lines. This learning from international and local expert can help to elevate the CML management to improve patient care.
The Malaysian Society of Haematology (MSH) is pleased to share that abstract submissions are now open for the 6th Annual Scientific Meeting of the Association for Haemophilia and Allied Disorders – Asia Pacific (AHAD-AP).
This meeting provides an excellent opportunity for healthcare professionals involved in haemophilia and inherited bleeding disorders to showcase their research, clinical experience, quality improvement initiatives, and multidisciplinary care projects on a regional platform.
We warmly encourage colleagues from Malaysia and across the Asia-Pacific region to consider submitting their work and contributing to the advancement of haemophilia care.
Please refer to the poster below for submission details and further information.
As Highlights of ASH in Asia-Pacific 2026 (HOA 2026) is not directly accredited within the CPD system, all attendees are required to submit their CPD claims individually after the meeting.
Please follow these Step-by-Step Guide (with Visual Reference) for manual CPD application
Step 1 – Open MMA App
Open the MMA mobile application and navigate to and select Events from the bottom menu.
Step 2 – Select Manual Submission
Scroll to the bottom and select Manual Submission.
Step 3 – Select Manual Submission
Click Create Submission to begin a new CPD request.
Event Title: Highlights of ASH in Asia Pacific 2026
Description: [Suggested] Participation in the Highlights of ASH in Asia-Pacific 2026, an international haematology scientific meeting organised by the American Society of Hematology (ASH) and held in Kuala Lumpur, Malaysia. The meeting brought together delegates from 17 countries, including 200 Malaysian delegates featuring expert-led sessions covering advances in leukaemia, lymphoma, myeloma, thrombosis, transplantation, and emerging therapies.
Step 6 – Upload Supporting Documents
Please upload the following:
Event Programme (download the attached jpeg below)
Certificate of Attendance (issued in ASH apps, after completion of the evaluation form - please convert to image file)
Important Notes
CPD submission should be done after the event
Both programme and certificate are required for approval
Incomplete submissions may be rejected by MMA
Closing
Should you encounter any difficulties with submission, please feel free to reach out to the MSH Secretariat. We hope you found the meeting academically enriching and clinically valuable.